CRISPR/Cas9 system and its applications in nervous system diseases.

Authors:
Jiang H; Tang M; Xu Z; Wang Y; Li M and 4 more

Journal:
Genes Dis

Publication Year: 2023

DOI:
10.1016/j.gendis.2023.03.017

PMCID:
PMC10491921

PMID:
37692518

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Genes Dis

Abbreviation: Genes Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics & Heredity

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fib…
Xu Z; Davies ER; Yao L and 11 more (2024) - Transparency Score: 4/6
Advances in oral mesenchymal stem cell-derived extracellular vesicles in health and disease.
Luo H; Birjandi AA; Ren F and 4 more (2023) - Transparency Score: 3/6
A <i>BBS4</i> mutation causes autosomal dominant polycystic liver disease.
Cui Y; Xu W; Liu J and 6 more (2023) - Transparency Score: 3/6
An analysis of the transcriptional landscape in hypoxia-treated primary nucleus pulposus cells.
Peng Z; Wang Z; Guo S and 7 more (2023) - Transparency Score: 3/6
A novel preimplantation genetic testing strategy for a subtelomeric genetic disorder: A case study.
Chen S; Wang L; Chen L and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interests The authors report no conflict of interests in this work."

Evidence found in paper:

"Funding This study was funded by the 10.13039/501100001809National Natural Science Foundation of China (No. 82271747)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025